https://myhealth.alberta.ca/health/medications/Pages/conditions.aspx?hwid=fdb1853
Enasidenib - Oral
oral
https://clinicaltrials.stanford.edu/trials/p/NCT05282459.html
Phase Ib/II Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation
Stanford Health Care delivers the highest levels of care and compassion. SHC treats cancer, heart disease, brain disorders, primary care issues, and many more.